Literature DB >> 10764028

Effect of age and Helicobacter pylori infection on gastric acid secretion.

K Haruma1, T Kamada, H Kawaguchi, S Okamoto, M Yoshihara, K Sumii, M Inoue, S Kishimoto, G Kajiyama, A Miyoshi.   

Abstract

BACKGROUND: Whether gastric acid secretion decreases with age is still controversial. With the discovery of Helicobacter pylori, the association of this bacterium with gastric acid secretion has also been discussed. The aim of this study was to investigate the relationship between gastric acid secretion, age and H. pylori infection.
METHODS: The presence of H. pylori infection, the grade of fundic atrophic gastritis (FAG), and gastric acid secretion were investigated in 280 subjects without localized lesions in the upper gastrointestinal tract. Helicobacter pylori infection was confirmed by Giemsa and immunohistochemical staining, and FAG of biopsy specimens was graded on a scale of 0-4.
RESULTS: Both basal and maximal acid output decreased with age in H. pylori-positive subjects, while they did not change with age in H. pylori-negative subjects. Gastric acid secretion decreased with the progression of FAG. An age-correlated decrease in gastric acid secretion in H. pylori-positive subjects depended on an increasing prevalence of FAG with age.
CONCLUSIONS: In the population studied, advancing age had no influence on gastric acid secretion in H. pylori-negative subjects. Gastric acid secretion decreases with age in H. pylori-positive subjects because of the increasing prevalence of FAG with age.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10764028     DOI: 10.1046/j.1440-1746.2000.02131.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  36 in total

1.  Adverse cardiovascular outcomes associated with concurrent use of clopidogrel or ticlopidine and proton-pump inhibitors in patients undergoing percutaneous coronary intervention.

Authors:  Atsuko Nakayama; Hiroyuki Morita; Jiro Ando; Hideo Fujita; Hiroshi Ohtsu; Ryozo Nagai
Journal:  Heart Vessels       Date:  2012-03-30       Impact factor: 2.037

Review 2.  The clinical implications of ageing for rational drug therapy.

Authors:  Shaojun Shi; Klaus Mörike; Ulrich Klotz
Journal:  Eur J Clin Pharmacol       Date:  2008-01-05       Impact factor: 2.953

3.  The polymorphism interleukin 8 -251 A/T influences the susceptibility of Helicobacter pylori related gastric diseases in the Japanese population.

Authors:  M Ohyauchi; A Imatani; M Yonechi; N Asano; A Miura; K Iijima; T Koike; H Sekine; S Ohara; T Shimosegawa
Journal:  Gut       Date:  2005-03       Impact factor: 23.059

Review 4.  Aging and the intestine.

Authors:  Laurie Drozdowski; Alan B R Thomson
Journal:  World J Gastroenterol       Date:  2006-12-21       Impact factor: 5.742

5.  Early effects of Lansoprazole orally disintegrating tablets on intragastric pH in CYP2C19 extensive metabolizers.

Authors:  Hatsushi Yamagishi; Tomoyuki Koike; Shuichi Ohara; Toru Horii; Ryousuke Kikuchi; Shigeyuki Kobayashi; Yasuhiko Abe; Katsunori Iijima; Akira Imatani; Kaori Suzuki; Takanori Hishinuma; Junichi Goto; Tooru Shimosegawa
Journal:  World J Gastroenterol       Date:  2008-04-07       Impact factor: 5.742

6.  Gastric histology, serological markers and age as predictors of gastric acid secretion in patients infected with Helicobacter pylori.

Authors:  M H Derakhshan; E El-Omar; K Oien; D Gillen; V Fyfe; J E Crabtree; K E L McColl
Journal:  J Clin Pathol       Date:  2006-04-27       Impact factor: 3.411

7.  Helicobacter pylori infection increases the risk of colorectal adenoma and adenocarcinoma, especially in women.

Authors:  Shunji Fujimori; Teruyuki Kishida; Tsuyoshi Kobayashi; Yoshihisa Sekita; Tsuguhiko Seo; Kazuhiro Nagata; Atsushi Tatsuguchi; Katya Gudis; Kimiyoshi Yokoi; Noritake Tanaka; Kiyohiko Yamashita; Takashi Tajiri; Yoshiharu Ohaki; Choitsu Sakamoto
Journal:  J Gastroenterol       Date:  2005-09       Impact factor: 7.527

8.  Gastric acid normosecretion is not essential in the pathogenesis of mild erosive gastroesophageal reflux disease in relation to Helicobacter pylori status.

Authors:  Tomohiko Shimatani; Masaki Inoue; Nobue Harada; Yoko Horikawa; Masuo Nakamura; Susumu Tazuma
Journal:  Dig Dis Sci       Date:  2004-05       Impact factor: 3.199

9.  Assessing the efficacy of famotidine and rebamipide in the treatment of gastric mucosal lesions in patients receiving long-term NSAID therapy (FORCE--famotidine or rebamipide in comparison by endoscopy).

Authors:  Jun-ichi Yamao; Eiryo Kikuchi; Masami Matsumoto; Masaki Nakayama; Tatsuichi Ann; Hideyuki Kojima; Akira Mitoro; Motoyuki Yoshida; Masaaki Yoshikawa; Hiroshi Yajima; Yoshizumi Miyauchi; Hiroshi Ono; Koichi Akiyama; Goro Sakurai; Yoshikazu Kinoshita; Ken Haruma; Yoshinori Takakura; Hiroshi Fukui
Journal:  J Gastroenterol       Date:  2007-02-06       Impact factor: 7.527

10.  Age and Prevalence of Esophageal Reflux Disease in Japanese Patients with Type 2 Diabetes Mellitus: The Dogo Study.

Authors:  Yoshio Ikeda; Shinya Furukawa; Takenori Sakai; Tetsuji Niiya; Hiroaki Miyaoka; Teruki Miyake; Shin Yamamoto; Hidenori Senba; Yasunori Yamamoto; Eiji Arimitsu; Sen Yagi; Hiroki Utsunomiya; Keiko Tanaka; Eiji Takeshita; Bunzo Matsuura; Yoshihiro Miyake; Yoichi Hiasa
Journal:  Dig Dis Sci       Date:  2016-09-22       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.